Bioventus Executive and Leadership Team

Anthony Bihl, the Chief Executive Officer at Bioventus, directs the company's overarching strategy and operational execution. Bihl guides Bioventus in its mission to deliver innovations for active healing, focusing on clinically effective and cost-efficient medical treatments. Overseeing global operations, the Chief Executive Officer ensures alignment with corporate targets for market expansion and product development. This leadership role involves driving the company's growth through strategic acquisitions and internal product innovation, directly impacting the company's market position in minimally invasive medical solutions. By optimizing the business model, Anthony Bihl secures long-term financial stability and enhances the body's natural healing processes through advanced therapies.

Michael McManus, the President and Chief Executive Officer of Misonix Inc. at Bioventus, spearheads the strategic direction and operational management of the Misonix division. McManus drives the integration and growth of Misonix's innovative technologies within Bioventus's broader active healing portfolio. Overseeing the Misonix business unit, the President and Chief Executive Officer of Misonix Inc. ensures the development and market introduction of advanced solutions that align with Bioventus's commitment to minimally invasive medical treatments. This critical role involves fostering synergies between Misonix's unique capabilities and Bioventus's established market presence, thereby enhancing the company's overall offering in restorative therapies. By focusing on technological advancement and market penetration, Michael McManus directly contributes to expanding Bioventus's impact on patient outcomes and healthcare efficiency.

Mark Singleton, the Senior VP & Chief Financial Officer at Bioventus, directs the company's financial strategy, planning, and reporting functions. Singleton ensures robust financial management to support Bioventus's global operations and its commitment to delivering innovative active healing solutions. Overseeing all financial activities, the Senior VP & Chief Financial Officer manages capital allocation, investor relations, and fiscal discipline to drive profitable growth and market expansion. This leadership role is critical in evaluating investment opportunities, including product development and acquisitions, that align with the company's goal of providing clinically effective, cost-efficient medical treatments. By maintaining strong financial health, Mark Singleton directly enables Bioventus to pursue its mission of enhancing the body's natural healing processes through advanced, minimally invasive therapies.

Keith McBride, the Chief Technology Officer & Vice President, Research Development Pain & Restorative Therapies at Bioventus, architects the company's technological roadmap and oversees the research and development of innovative solutions. McBride leads the charge in creating next-generation products that enhance the body's natural healing processes, particularly within pain management and restorative therapies. Directing the R&D pipeline, the Chief Technology Officer & Vice President, Research Development Pain & Restorative Therapies ensures that Bioventus remains at the forefront of medical innovation, focusing on clinically effective and cost-efficient treatments. This leadership position involves managing cross-functional teams to accelerate product development cycles and bring novel therapies to market. By championing technological advancements, Keith McBride directly supports Bioventus's mission to provide minimally invasive medical solutions that improve patient lives.

Helen Leupold, the Senior Vice President, Chief Human Resources Officer at Bioventus, directs the company's global human capital strategy and organizational development initiatives. Leupold cultivates a high-performance culture that supports Bioventus's mission of active healing and innovation across all business functions. Overseeing talent acquisition, employee engagement, and leadership development, the Senior Vice President, Chief Human Resources Officer ensures that Bioventus attracts and retains top talent essential for bringing effective medical treatments to market. This role is pivotal in aligning the workforce with the company's strategic objectives, fostering an environment conducive to developing cost-efficient, minimally invasive solutions. By championing employee growth and organizational effectiveness, Helen Leupold directly contributes to Bioventus's sustained success and its ability to enhance patient outcomes through its unique product offerings.